Skip to content

Clinical trials

Terminated Idiopathic Pulmonary Fibrosis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Status: Terminated Country / region: Germany Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20131
20172
20182
20191
20201
20212
20222
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences3
Hoffmann-La Roche2
Lakefront Biotherapeutics NV2
Novartis Pharmaceuticals2
Amgen1
Boehringer Ingelheim1
Celgene1
Genentech, Inc.1
GlaxoSmithKline1
Kyntra Bio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis17
Pulmonary Fibrosis5
Lung Diseases, Interstitial3
Fibrosis2
Idiopathic Interstitial Pneumonias2
Anxiety Disorders1
Hypertension, Pulmonary1
Lung Diseases1
Pathologic Processes1
Pulmonary Disease, Chronic Obstructive1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.